Corporate Partnerships
Long-term collaboration with industry, structured so that commercial capability serves accessible healthcare.
What each side actually brings
Companies hold capabilities that research centres do not: manufacturing at scale, distribution networks, regulatory experience across markets, and capital. A research centre holds capabilities companies often lack: independent scientific credibility, clinical and community access, and a mandate that permits work with no commercial return.
A well-structured partnership uses both. A badly structured one produces an excellent product priced beyond the population it was meant for. The difference is decided in the terms, agreed at the start rather than negotiated once a product exists.
How corporate partnerships work
Co-development
Manufacturing
Research funding
Skills & secondments
Equipment provision
Programme sponsorship
Terms we agree before any partnership begins
- Access and affordability commitments for the intended population
- The Center's right to publish findings, including unfavourable ones
- Scientific independence — findings are not subject to commercial approval
- Clear allocation of intellectual property
- Transparent declaration of the partnership on relevant outputs
- No access to confidential patient data
- Defined contributions, responsibilities and review points
- Terms for ending the partnership
Where partnerships are declined
We will not enter arrangements that condition support on a particular finding, restrict publication of an unfavourable result, or produce something the population it was designed for could not afford.
Explore a corporate partnership
If your organisation is interested in a collaboration on these terms, we would welcome a conversation.